Community
Company
News
Contact Us
Sign in

Please select the option that best describes you:

Topics: Rheumatology • Vasculitis

How do you treat IgA vasculitis with gastrointestinal involvement?

Related Questions

Can cryoglobulins be present in the setting of severe acrocyanosis without evidence of active cryoglobulinemic vasculitis?

How would you approach induction therapy for EGPA with neurological involvement in a middle-aged patient with foot drop and axonal peripheral neuropathy on EMG, but otherwise no evidence of GI/renal/cardiovascular involvement?

Would you consider upadacitinib for GCA in a patient with history of breast cancer now in remission?

Would you add a DMARD such as methotrexate for a patient with GCA and partial response to tocilizumab but inability to taper prednisone below 10mg daily?

How do you approach treatment of livido vasculitis?

Would you consider re-dosing rituximab in a patient with ANCA vasculitis (early glomerulonephritis, pulmonary nodules, sinus symptoms) who experiences a flare of the disease and return of CD19 cells 3 months after initial rituximab administration?

What treatment regimen would you recommend for a patient with biopsy-proven giant cell arteritis and diffuse cutaneous systemic sclerosis?

How would you approach management of a young woman referred for isolated anterior uveitis (now resolved), in the absence of systemic manifestations or end-organ involvement, but with serologies notable for strongly positive PR3 (negative c-ANCA)?

Would you pursue a kidney biopsy in a patient with stable stage 1 AKI, bland urine sediment, and a positive MPO titer without systemic signs of vasculitis?

How would you approach failure of maintenance therapy (Azathioprine) for PR3 positive, c-ANCA positive, pulmonary–renal vasculitis previously induced with cyclophosphamide, with a history of anaphylaxis to rituximab?

Copyright © 2026 Mednet
All Rights Reserved.